Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPS6KA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC93429 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OVOL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLCCI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABTB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LBX1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on